United States Steel Corporation Corp. (NYSE:X) announced that interested stockholders, investors and others may listen to the company's third quarter 2014 conference call with securities analysts on Wednesday, Oct. 29, 2014, at 8:30 a.m. EDT. United States Steel Corp. (NYSE:X) in last trading activity fell -2.54% to close at $35.24. Company weekly performance is 7.11% while its quarterly performance stands at 28.24%. United States Steel Corp. (NYSE:X) is -24.30% away from its 52 week high. Oracle Corporation (NYSE:ORCL) recently launched Oracle Enterprise Metadata Management 12c to expand its data integration portfolio. The company designs the new enterprise solution to reduce the risks associated with compliance and create data and business transparency to ensure a successful governance program for the customers. On last trading day Oracle Corporation (NYSE:ORCL) fell -1.85% to close at $37.64. Its volatility for the week is 2.51% while volatility for the month is 2.00%. ORCL's sales growth for past 5 years was 10.50% and its EPS growth for past 5 years was 16.90%. Oracle Corporation (NYSE:ORCL) monthly performance is -2.76%. California-based Pandora Media Inc. (NYSE:P) has hired the former general counsel of Electronic Arts Inc. to serve as head of the legal department for the music streaming service. On last trading day Pandora Media Inc (NYSE:P) decreased -1.05% to close at $22.71. Its volatility for the week is 4.50% while volatility for the month is 4.85%. P's sales growth for past 5 years was 98.90% and its EPS growth for past 5 years was 5.60%. Pandora Media Inc (NYSE:P) monthly performance is -9.34%. Yelp Inc. (NYSE:YELP) reported net income for the third quarter of $3.6 million or $0.05 per share, compared to a net loss of $2.3 million or $0.04 per share for the year-ago quarter. Net revenue for the third quarter rose 67% to $102.46 million from $61.18 million a year ago. Yelp, Inc. (NYSE:YELP) has 11.16% insider ownership while its institutional ownership stands at value missing. In last trading activity company's stock closed at $70.23.On October 6, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) received a $40 million milestone payment from its worldwide collaboration partner, Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP), upon the US Food and Drug Administration's approval last week of RELISTOR® Subcutaneous Injection for opioid-induced constipation in patients with chronic non-cancer pain. On Wednesday shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) closed at $4.56. Company's sales growth for last 5 years was -34.90% and EPS growth for next 5 years is recorded as 25.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
